NEUROPACE INC. - COMMON STOCK

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates

08 Jan 2024 07:03:00 By Nasdaq GlobeNewswire

NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study

21 Dec 2023 07:07:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference

19 Dec 2023 16:30:00 By Nasdaq GlobeNewswire

NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration

04 Dec 2023 17:07:00 By Nasdaq GlobeNewswire

NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting

01 Dec 2023 08:00:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference

21 Nov 2023 08:00:00 By Nasdaq GlobeNewswire

NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

06 Nov 2023 16:03:00 By Nasdaq GlobeNewswire

NeuroPace Announces RNS System Enhancements Designed to Streamline Care

17 Oct 2023 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023

16 Oct 2023 17:01:49 By Nasdaq GlobeNewswire

NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference

20 Sep 2023 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Participate in Upcoming Investor Conferences

24 Aug 2023 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

08 Aug 2023 16:03:00 By Nasdaq GlobeNewswire

NeuroPace Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market

19 Jul 2023 16:03:00 By Nasdaq GlobeNewswire

NeuroPace to Report Second Quarter 2023 Financial Results on August 8, 2023

18 Jul 2023 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Announces CEO Transition

28 Jun 2023 16:03:00 By Nasdaq GlobeNewswire

NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales

24 May 2023 16:05:19 By Nasdaq GlobeNewswire

NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

04 May 2023 16:05:01 By Nasdaq GlobeNewswire

NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023

17 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference

03 Apr 2023 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results

02 Mar 2023 16:05:01 By Nasdaq GlobeNewswire